I have published many notes recently on FinTech companies and the evolution of the open banking paradigm. See why I am bullish on Marqeta and Upstart stocks.
Visa (NYSE:V – Get Rating) and Molecular Data (NASDAQ:MKD – Get Rating) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Institutional and Insider Ownership 81.3% of Visa shares are owned […]
Building the Food and Beverage Company of the Future With Greg Steltenpohl of Califia Farms onegreenplanet.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onegreenplanet.org Daily Mail and Mail on Sunday newspapers.
#BTColumn – The onus is on us (Part 1)
Article by July 20, 2021
Disclaimer: The views and opinions expressed by this author are their own and do not represent the official position of the Barbados TODAY Inc.
by
Adrian Sobers
“Yet you have made them [human beings] a little lower than God, and crowned them with glory and honour.” – (
Psalm 8:5, NRSV) “Glory to man in the highest! For Man is the master of things.” – (
Algernon Swinburne, Hymn of Man)
Whether interacting with scholars or the streets, Jesus grounded their misunderstanding(s) not in Scripture, but on their misunderstanding of, and/or failure to, accept them. He placed the onus on us: “have you never read in the Scriptures …” (
Markets
In a report released today, Dan Dolev from Mizuho Securities maintained a Buy rating on Visa (V – Research Report), with a price target of $275.00. The company’s shares closed last Tuesday at $229.91, close to its 52-week high of $232.95.
Dolev has an average return of 11.2% when recommending Visa.
According to TipRanks.com, Dolev is ranked #734 out of 7483 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Visa with a $259.27 average price target, representing a 12.2% upside. In a report issued on April 15, Jefferies also maintained a Buy rating on the stock with a $260.00 price target.